Affluent Partners Holdings' (HKG:1466) subsidiary Beijing Baijin Biotechnology agreed to cooperate with Hangzhou Changwei Hospital to establish a smart medical service model with specialized expertise and treatment, a Wednesday filing with the Hong Kong Exchange said.
The parties will utilize their complementary advantages to create a smart medical service system which will cover medical treatment, teaching, and scientific research.
The service model will include a smart medical information system, specialty and disease-based treatment and management smart medical service platforms, and a specialty-specific smart medical management system.
The Jewelry maker and trader's shares were up 14% on Wednesday's close.
Price (HKD): $0.57, Change: $+0.070, Percent Change: +14.00%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.